LEGALDIGMLEGALDIGM
    ← Code of Federal Regulations
    Beta
    21 CFR § 520.370

    21 CFR § 520.370 — § 520.370 Cefpodoxime tablets.

    Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.

    Analyze this law with AI
    § 520.370 Cefpodoxime tablets. (a) Specifications. (1) Each tablet contains cefpodoxime proxetil equivalent to 100 or 200 milligrams (mg) cefpodoxime. (2) Each chewable tablet contains cefpodoxime proxetil equivalent to 100 or 200 mg cefpodoxime. (b) Sponsors. See sponsors in § 510.600(c) of this chapter for uses as follows: (1) No. 017033 for use of product in paragraph (a)(1) of this section as in paragraph (c) of this section. (2) No. 054771 for use of products in paragraph (a) of this section as in paragraph (c) of this section. (c) Conditions of use in dogs —(1) Amount. 5 to 10 mg per kilogram (2.3 to 4.5 mg per pound) body weight daily for 5 to 7 days, or for 2 to 3 days beyond the cessation of clinical signs, up to a maximum of 28 days. (2) Indications for use. For the treatment of skin infections (wounds and abscesses) caused by susceptible strains of Staphylococcus pseudintermedius , S. aureus , Streptococcus canis (group G, beta-hemolytic), Escherichia coli , Pasteurella multocida , and Proteus mirabilis. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [69 FR 52815, Aug. 30, 2004, as amended at 78 FR 5714, Jan. 28, 2013; 79 FR 28819, May 20, 2014; 80 FR 13229, Mar. 13, 2015; 82 FR 12169, Mar. 1, 2017; 88 FR 16547, Mar. 20, 2023]

    Related guides, FAQ and contract templates